Evidence map›Paper›PMID 40415630›Full record

ArticleBJU international2025

Robot-assisted vs open kidney transplantation from deceased donors.

Luca Afferi, Angelo Territo, Alessio Pecoraro, Lorenzo Masieri, Milla Ortved, Julia Abildgaard Dagnæs-Hansen, Begonya Etcheverry, Andrea Gallioli, Donato Cannoletta, Joris Vangeneugden and 13 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in BJU international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Luca AfferiDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5472-1933
Angelo TerritoDepartment of Urology, Fundació Puigvert, Barcelona, Spain.
Alessio PecoraroUnit of Oncology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0002-0667-1468
Lorenzo MasieriUnit of Oncology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Milla OrtvedUrological Research Unit, Rigshospitalet, Copenhagen, Denmark.
Julia Abildgaard Dagnæs-HansenUrological Research Unit, Rigshospitalet, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-2719-2885
Begonya EtcheverryDepartment of Urology, Hospital Bellvitge, Bellvitge, Spain.
Andrea GallioliDepartment of Urology, Fundació Puigvert, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3316-5691
Donato CannolettaDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Joris VangeneugdenDepartment of Urology, Ghent University Hospital, Ghent, Belgium.
Jeremy MercierDepartment of Urology, Hospital of Toulouse, Toulouse, France.ORCID https://orcid.org/0009-0008-0630-364X
Thomas PrudhommeDepartment of Urology, Hospital of Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0003-3601-9339
Isacco DonniniDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Antonino VazzanaDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Malene RohrstedUrological Research Unit, Rigshospitalet, Copenhagen, Denmark.
Francesc ViguésDepartment of Urology, Hospital Bellvitge, Bellvitge, Spain.
Nicolas DoumercDepartment of Urology, Hospital of Toulouse, Toulouse, France.
Karel DecaesteckerDepartment of Urology, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0003-0767-940X
Joan PalouDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Riccardo CampiUnit of Oncology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0001-5237-0888
Sergio SerniUnit of Oncology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Andreas RoderUrological Research Unit, Rigshospitalet, Copenhagen, Denmark.
Alberto BredaDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo test the hypothesis that the type of surgical approach, robot-assisted kidney transplantation (RAKT) vs open kidney transplantation (OKT), impacts intra-operative and postoperative surgical outcomes of patients receiving kidney transplantation from deceased donors. MATERIALS AND

methodsThis was a multicentre retrospective cohort study including 676 patients who received RAKT or OKT in the period 2015 to 2023 in one of seven European academic centres. Patient heterogeneity at baseline was balanced using 2:1 nearest neighbour propensity-score matching. Intra- and postoperative complications were reported according to the Clavien-Dindo classification system. Kaplan-Meier estimates and the log-rank test were used to compare dialysis-free survival (DFS), graft survival (GS), reintervention-free survival (RFS) and overall survival (OS) according to the surgical approach used.

resultsAfter propensity-score matching, two cohorts of 72 recipients (65%) in the OKT group and 37 (35%) in the RAKT group with similar baseline characteristics were obtained. The site of transplantation was the right iliac fossa in 59 (82%) and 28 patients (76%) undergoing OKT and RAKT, respectively. RAKT was associated with shorter rewarming time (53 vs 39 min), total vascular anastomosis time (55 vs 36 min), and arterial (25 vs 17 min) and venous (28 vs 18 min) anastomosis times (all P < 0.001), whereas OKT was associated with reduced surgical time (180 vs 200 min; P = 0.01). Intra-operative complications were more commonly reported in recipients undergoing OKT (8.3% vs 2.7%; P = 0.4). During follow-up, no differences in terms of postoperative complications, DFS, GS, RFS or OS were detected.

conclusionsThis is the largest comparative study of RAKT vs OKT in the deceased donor setting. While it confirms the safety of RAKT from deceased donors, it underscores the superiority of RAKT in selected patients in terms of achieving vascular anastomosis and rewarming time in a shorter timeframe.

Indexed as

Kidney TransplantationRobotic Surgical ProceduresAdultFemaleGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsPropensity ScoreRetrospective StudiesTissue DonorsTreatment Outcomedeceased donorskidney transplantationopen kidney transplantationrenal transplantationrobot‐assisted kidney transplantation

Identifiers

PMID40415630
PMCPMC12343986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.